Beautiful Virgin Islands

Thursday, Oct 30, 2025

Silicon Valley is coming for your gut biome

Silicon Valley is coming for your gut biome

Venture capitalists who have made fortunes investing in software and hardware are putting tens of millions of dollars into companies that make probiotic pills.
Cryptocurrency hasn’t worked out so well for tech investors. Neither has the metaverse so far. Self-driving cars have been slow to arrive, and social media doesn’t have the hyper-fast growth that it did a few years ago. 

So where can a savvy tech investor turn these days in search of the next big idea? Two words: dietary supplements.   

Some venture capitalists who have made fortunes investing in software and hardware are putting tens of millions of dollars into companies that make probiotic pills, capsules filled with plant extracts and other nutritional supplements as a potential new frontier. 

As a consumer product, supplements are associated more with the Kardashians or Joe Rogan than with Silicon Valley. The industry is infamous for its lack of regulation under a 1994 federal law that exempts supplements from most Food and Drug Administration oversight, and it has boomed in recent years despite questions about efficacy.

Now, venture capitalists are betting that advances in DNA sequencing and related techniques will usher in a new and more credible wave of supplements, focused especially on gut health. 

Roelof Botha, the managing partner of Sequoia Capital, one of the largest venture capital firms in the world, is among those buying in. He said there’s a “societal reawakening” about the complex biome of the human gut where hundreds of species of bacteria live. 

“Inadvertently, we entered this era where we had an adversarial stance between humans and the rest of nature,” he said. “We overused antibiotics. We overused soaps. And now we’re going back into balance.” 

Botha is best known in the tech industry for early bets on Instagram and YouTube, but he said he became interested in gut health after Sequoia invested in genetics testing companies such as 23andMe. That interest led Sequoia to invest in Pendulum, a San Francisco startup that’s selling probiotic supplements. 

He takes them himself. “There’s nothing like getting live microbes into your system,” he said. 

Sequoia has plenty of company. In 2021, venture capitalists invested $488 million in probiotic companies and other supplement startups worldwide, five times what they invested five years earlier, according to PitchBook, a research firm that tracks startup investments. The money last year went to 99 separate funding deals — a record high for activity, according to Pitchbook. 

The money includes investments from pharmaceutical and food giants, but also from Silicon Valley elite who don’t come from the world of biotech. 

Khosla Ventures, headed by a co-founder of Sun Microsystems, is also an investor in Pendulum. Y Combinator, a well-known tech incubator, has a stake in Persephone Biosciences, a startup researching potential cancer treatments involving gut microbes. Social Capital, another large venture capital firm, invests in a startup called ZBiotics that sells a probiotic drink as a hangover cure. 

It’s a welcome development for some startup founders. 

“Five years ago, the investors were health investors who had a background in health, or food investors who had a background in food,” said Sofia Elizondo, a co-founder of Brightseed, a San Francisco startup that’s developing gut health products. 

“And what we’re finding is a lot of crossover investor interest now, where a lot of capital shares the thesis that precise, molecular-level proactive health is the way of the future,” she said. 

There’s already been one cautionary tale about how a probiotic startup can go wrong. uBiome, a San Francisco startup that promised to give people insight into their microbiome based on tests of fecal matter, attracted tens of millions of dollars in investments including from the venture capital firms Andreessen Horowitz and Y Combinator. 

But last year, federal prosecutors said uBiome’s tests weren’t scientifically valid and they charged the founders, Zachary Apte and Jessica Richman, with fraud. The two were living in Germany as of last year and have not been extradited to face the charges, The Wall Street Journal reported. Their lawyers did not respond to requests for comment. 

Still, the episode hasn’t soured venture capitalists on the potential of “nutraceuticals,” which fit in with a certain strain of Silicon Valley self-improvement culture known as biohacking.

As a business, probiotics and other supplements have at least two advantages that venture capitalists typically look for. One is steady recurring revenue, which comes from people taking pills daily or food manufacturers using them as additives to control insulin, improve digestion or attempt weight-loss. 

The other is a lack of strict regulation. The ingredients must be generally regarded as safe and the manufacturers can’t market supplements as more effective than the research shows, but supplements don’t need to go through the same rigorous approval process as pharmaceuticals. 

Botha, from Sequoia Capital, said he believes genetics research has similar potential to microchips a generation ago, when microchip power was expected to double every two years under a principle called Moore’s Law. 

DNA sequencing has “progressed faster than Moore’s law,” he said. And that, he added, is what makes the sector a good target for Silicon Valley. “It’s about understanding biology as an information science.” 

Elisa Marroquín, an assistant professor of nutritional sciences at Texas Christian University, said that the science around the new wave of supplements is still new, but she said at least some tech startups seem to be on the right track. She said she doesn’t have a financial relationship with any startups, though she has spoken with them about obtaining samples for research.

“We’re still very early in the understanding of these bacterial species,” Marroquín said. She co-wrote a review of the science this year, and said future probiotic supplements have promise compared to supplements that have been available for decades. 

“I do believe they’re going to have stronger effects on our health than the current probiotics that are on the market,” she said. 

But part of the challenge for the new wave of supplements startups is to change the perception of their industry as unscientific or as a kind of Northern California witchcraft. 

Among certain scientists, “probiotics are definitely this voodoo,” said Colleen Cutcliffe, a co-founder of Pendulum and its CEO. She has a doctorate in biochemistry from Johns Hopkins University, and her two co-founders also have doctorates. 

“In fact, in the first eight years of our company, I didn’t let anyone use the p-word to discuss our product,” she said, referring to probiotics. “I said, ‘This is a microbiotic intervention.’”

Pendulum sells a few products so far, including a supplement with akkermansia muciniphila, a gut bacteria that it markets as a “next generation probiotic” linked to controlling diet-induced obesity. The bacteria is difficult to manufacture alive because it can die when it comes into contact with oxygen, Cutcliffe said, so Pendulum has built a proprietary process that keeps oxygen out. 

Cutcliffe said there are tens of thousands of gut bacteria strains still to be studied, with a $60 billion global probiotic industry waiting for new products — which is what has caught investors’ eyes. 

“What appealed to these folks was the idea of category creation, and an already existing huge market that hadn’t had any innovation in a long time,” she said.
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
UK and Vietnam Sign Landmark Migration Deal to Fast-Track Returns of Irregular Arrivals
UK Drug-Pricing Overhaul Essential for Life-Sciences Ambition, Says GSK Chief
Princesses Beatrice and Eugenie Temporarily Leave the UK Amid Their Parents’ Royal Fallout
UK Weighs Early End to Oil and Gas Windfall Tax as Reeves Seeks Investment Commitments
UK Retail Inflation Slows as Shop Prices Fall for First Time Since Spring
Next Raises Full-Year Profit Guidance After Strong Third-Quarter Performance
Reform UK’s Lee Anderson Admits to 'Gaming' Benefits System While Advocating Crackdown
United States and South Korea Conclude Major Trade Accord Worth $350 Billion
Hurricane Melissa Strikes Cuba After Devastating Jamaica With Record Winds
Vice President Vance to Headline Turning Point USA Campus Event at Ole Miss
U.S. Targets Maritime Narco-Routes While Border Pressure to Mexico Remains Limited
Bill Gates at 70: “I Have a Real Fear of Artificial Intelligence – and Also Regret”
Elon Musk Unveils Grokipedia: An AI-Driven Alternative to Wikipedia
Saudi Arabia Unveils Vision for First-Ever "Sky Stadium" Suspended Over Desert Floor
Amazon Announces 14 000 Corporate Job Cuts as AI Investment Accelerates
UK Shop Prices Fall for First Time Since March, Food Leads the Decline
London Stock Exchange Group ADR (LNSTY) Earns Zacks Rank #1 Upgrade on Rising Earnings Outlook
Soap legend Tony Adams, long-time star of Crossroads, dies at 84
Rachel Reeves Signals Tax Increases Ahead of November Budget Amid £20-50 Billion Fiscal Gap
NatWest Past Gains of 314% Spotlight Opportunity — But Some Key Risks Remain
UK Launches ‘Golden Age’ of Nuclear with £38 Billion Sizewell C Approval
UK Announces £1.08 Billion Budget for Offshore Wind Auction to Boost 2030 Capacity
UK Seeks Steel Alliance with EU and US to Counter China’s Over-Capacity
UK Struggles to Balance China as Both Strategic Threat and Valued Trading Partner
Argentina’s Markets Surge as Milei’s Party Secures Major Win
British Journalist Sami Hamdi Detained by U.S. Authorities After Visa Revocation Amid Israel-Gaza Commentary
King Charles Unveils UK’s First LGBT+ Armed Forces Memorial at National Memorial Arboretum
At ninety-two and re-elected: Paul Biya secures eighth term in Cameroon amid unrest
Racist Incidents Against UK Nurses Surge by 55%
UK Chancellor Rachel Reeves Cites Shared Concerns With Trump Administration as Foundation for Early US-UK Trade Deal
Essentra plc: A Closer Look at a UK ‘Penny Stock’ Opportunity Amid Market Weakness
U.S. and China Near Deal to Avert Rare-Earth Export Controls Ahead of Trump-Xi Summit
Justin time: Justin Herbert Shields Madison Beer with Impressive Reflex at Lakers Game
Russia’s President Putin Declares Burevestnik Nuclear Cruise Missile Ready for Deployment
Giuffre’s Memoir Alleges Maxwell Claimed Sexual Act with Clooney
House Republicans Move to Strip NYC Mayoral Front-Runner Zohran Mamdani of U.S. Citizenship
Record-High Spoiled Ballots Signal Voter Discontent in Ireland’s 2025 Presidential Election
Philippines’ Taal Volcano Erupts Overnight with 2.4 km Ash Plume
Albania’s Virtual AI 'Minister' Diella Set to 'Birth' Eighty-Three Digital Assistants for MPs
Tesla Unveils Vision for Optimus V3 as ‘Biggest Product of All Time’, Including Surgical Capabilities
Francis Ford Coppola Auctions Luxury Watches After Self-Financed Film Flop
Convicted Sex Offender Mistakenly Freed by UK Prison Service Arrested in London
United States and China Begin Constructive Trade Negotiations Ahead of Trump–Xi Summit
U.S. Treasury Sanctions Colombia’s President Gustavo Petro over Drug-Trafficking Allegations
Miss USA Crowns Nebraska’s Audrey Eckert Amid Leadership Overhaul
‘I Am Not Done’: Kamala Harris Signals Possible 2028 White House Run
NBA Faces Integrity Crisis After Mass Arrests in Gambling Scandal
Swift Heist at the Louvre Sees Eight French Crown Jewels Stolen in Under Seven Minutes
U.S. Halts Trade Talks with Canada After Ontario Ad Using Reagan Voice Triggers Diplomatic Fallout
Microsoft AI CEO: ‘We’re making an AI that you can trust your kids to use’ — but can Microsoft rebuild its own trust before fixing the industry’s?
×